BPG is committed to discovery and dissemination of knowledge
Articles in Press
6/24/2026 8:24:19 AM | Browse: 1 | Download: 0
Publication Name World Journal of Nephrology
Manuscript ID 121887
DOI 10.5527/wjn.121887
Country Pakistan
Category Urology & Nephrology
Manuscript Type Retrospective Cohort Study
Article Title Immunofluorescence-based reclassification of idiopathic membranoproliferative glomerulonephritis: Insights from a single-center cohort
Manuscript Source Invited Manuscript
All Author List Rahma Rashid, Ranil H Shrestha, Tabassum Elahi, Shaheera Shakeel and Muhammed Mubarak
Funding Agency and Grant Number
Corresponding Author Muhammed Mubarak, Department of Histopathology, Sindh Institute of Urology and Transplantation, Chand Bibi Road, Karachi 74200, Sindh, Pakistan. drmubaraksiut@yahoo.com
Key Words End-stage kidney disease; Membranoproliferative glomerulonephritis; Immune complex-mediated membranoproliferative glomerulonephritis; Complement-mediated membranoproliferative glomerulonephritis; Immunofluorescence
Core Tip Careful subclassification of membranoproliferative glomerulonephritis (MPGN) using immunofluorescence is essential, as immune complex-mediated MPGN and complement-mediated MPGN (C-MPGN) types differ in underlying mechanisms and outcomes. Although clinical and histopathological features at presentation may appear similar, subtle distinctions, such as stronger C3 deposition and lower serum C3 in C-MPGN, may provide a clue for accurate diagnosis. Immune complex-mediated MPGN is more common and tends to achieve higher remission rates, while C-MPGN may carry a poorer prognosis despite comparable progression to end-stage kidney disease. Long-term follow-up and tailored immunosuppressive strategies are critical for both subtypes to optimize renal outcomes and better understand disease trajectories in diverse populations.
Citation Rashid R, Shrestha RH, Elahi T, Shakeel S, Mubarak M. Immunofluorescence-based reclassification of idiopathic membranoproliferative glomerulonephritis: Insights from a single-center cohort. World J Nephrol 2026; In press
PDF 121887-in-press.pdf
Received
2026-04-03 08:44
Peer-Review Started
2026-04-03 08:46
First Decision by Editorial Office Director
2026-05-26 10:12
Return for Revision
2026-05-26 10:12
Revised
2026-06-05 10:54
Publication Fee Transferred
Second Decision by Editor
2026-06-24 02:41
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-06-24 08:24
Articles in Press
2026-06-24 08:24
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 2220-6124 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © Author(s) (or their employer(s)) 2026. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com